首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 93 毫秒
1.
本工作设计合成了6种新型氨·环己胺·羧酸根合铂(Ⅱ)类配合物[Pt(NH3)((?)-NH2)X2](a~f){其中,X=CH3COO-(乙酸根),CH2ClCOO-(氯乙酸根),C6H5-COO-(苯甲酸根),p-CH3O-C6  相似文献   

2.
自顺铂临床用于抗肿瘤药物以来,在铂配合物中寻找新的药物已成为研究的热点,现在已有顺铂、卡铂和奥沙利铂在广泛应用于临床。根据经典的构效关系,上千个新的铂类化合物被设计与合成出来。我们综述了铂(Ⅱ)类抗肿瘤药物近五年的研究状况,介绍了包括含有生物活性基团的铂(Ⅱ)配合物,具有空间位阻的铂(Ⅱ)配合物,反式铂(Ⅱ)配合物,含S、P配位原子铂(Ⅱ)配合物和多核铂(Ⅱ)配合物,总结了这些化合物的抗肿瘤机理、活性。  相似文献   

3.
本工作设计合成了6种新型氨·环己胺·羧酸根合铂!类配合物[Pt(NH3)(NH2)X2](a ̄f){其中,X=CH3COO-(乙酸根),CH2ClCOO-(氯乙酸根),C6H5-COO-(苯甲酸根),p-CH3O-C6H4-COO-(对甲氧基苯甲酸根),p-CH3-C6H4-COO-(对甲基苯甲酸根),p-NO2-C6H4-COO-(对硝基苯甲酸根)}。通过元素分析、摩尔电导、红外光谱、紫外光谱和1H核磁共振谱对配合物进行了表征。通过MTT法研究了配合物的体外抗肿瘤活性,通过流式细胞仪以及等离子体质谱研究了配合物对细胞周期的影响以及与细胞DNA的键合量;体外抗肿瘤活性测试表明,配合物(c ̄f)对EJ和HL-602种肿瘤细胞表现出好的活性,而且配合物(c),(d)和(e)对EJ和HL-602种肿瘤细胞的活性高于临床用药顺铂;配合物(a ̄f)对MCF-7、HCT-8和BGC-8233种肿瘤细胞的活性低于顺铂;它们能阻止HL-60和EJ细胞G2 M→G1期的进行;配合物(a ̄f)与HL-60和EJ细胞的DNA键合量从大到小的顺序为:c>d>e>cisplatin>f>a>b。  相似文献   

4.
周双生  薛璇  姜波  鲁传华  田玉鹏  蒋明华 《化学学报》2011,69(19):2335-2340
以乙醇为溶剂,用自制的姜黄素衍生物(L1~L4)和碘亚铂酸钾为原料,合成得到了4种姜黄素类铂(II)配合物(A~D),通过FT-IR、1H NMR、MS、差热热重和元素分析对所有目标化合物进行了结构表征.应用MTT(3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐)法研究了化合物体外对人肺腺癌A549、子宫颈癌...  相似文献   

5.
本工作设计合成了6种新型混胺羧酸根合铂(Ⅱ)类配合物[Pt((?)NH)(NH3)X2](a~f){其中,X=CH3COO-(乙酸根),CH3Cl COO-(氯乙酸根),CHCl2COO-(二氯乙酸根),C6H5-COO-(苯甲酸根),p-CH3-C6H4-COO-(对甲基苯甲酸根),p-CH3O-C6H4-COO-(对甲氧基苯甲酸根)}。通过元素分析、摩尔电导、差热分析、红外光谱、紫外光谱和 1H核磁共振谱对配合物进行了表征。通过MTT法研究了配合物的体外抗肿瘤活性,通过等离子体质谱研究了配合物与细胞DNA的键合量;体外抗肿瘤活性测试表明,配合物(a~f)对所测试的肿瘤细胞MCF-7、HCT-8和BGC-823没有表现出活性,但对EJ和HL-60两种肿瘤细胞表现出好的活性,而且配合物(d~f)对HL-60细胞的活性与顺铂相当。配合物(a~f)与HL-60细胞的DNA键合量与其作用浓度表现出一定的依赖性,从小到大的顺序为:cisplatin < c < b < a < f < e < d。  相似文献   

6.
铂类药物是当前一类主要的抗肿瘤药物。本文结合我们的研究工作综述了2000年以来文献报道的新型抗肿瘤铂类配合物的研究进展。按铂原子的价态、配体基团的结构特征、配位原子及中心原子的个数将其分为:含有生物活性基团的铂(Ⅱ)配合物;具有空间位阻的铂(Ⅱ)配合物;以P和S原子作为配位原子的铂(II)配合物;多核铂(Ⅱ)配合物;其他含有小分子配体的铂(Ⅱ)配合物和四价铂类配合物六类,并进行了总结。  相似文献   

7.
以顺-二碘-二环戊胺合铂(Ⅱ)为起始原料,经聚合反应和胺化反应制得顺式-二碘-异丙胺-环戊胺合铂(Ⅱ)(2);2分别与氯化钾,1,1-环丁基二羧酸钾和一水合草酸钾反应,合成了3个新型的铂配合物:顺式-二氯-异丙胺-环戊胺合铂(Ⅱ)(1a,收率36.6%),顺式-1,1-环丁基二羧酸-异丙胺-环戊胺合铂(Ⅱ)(1b,收率43.6%)和顺式-草酸-异丙胺-环戊胺合铂(Ⅱ)(1c,收率28.1%),其结构经1H NMR,IR,ESI-MS和元素分析表征。采用MTT法测定了1a~1c对肝癌(SMMC-7721),肺癌(A-549),乳腺癌(MCF-7)和结肠癌(SW480)的体外抑制活性。结果表明,1a~1c对部分癌细胞的IC50值小于40μm,具有一定的体外肿瘤生长抑制活性。  相似文献   

8.
20世纪60年代,美国密执安州立大学Rosenberg发现了顺铂具有抗癌活性,开辟了金属类抗肿瘤药物研究的新领域.经过40余年的研究,已相继成功开发了卡铂、奈达铂、奥沙利铂、舒铂、洛铂和双环铂等铂类抗肿瘤药物.虽然对于铂类抗肿瘤药物研究取得了一定的成绩,但在临床使用过程中也存在一些问题,如其毒副作用和抗药性,限制了其在临床上的进一步广泛应用.为了解决这些问题,科研工作者开始寻找新的金属类抗肿瘤药物以弥补现有铂类抗肿瘤药物的不足.在金属元素中,唯有钯(II)与铂(II)配合物具有相似或相同的结构特征,进而表现出相近或相似的化学性质.因此,继铂类抗肿瘤配合物后,钯(II)配合物作为潜在抗肿瘤药物成为一个诱人的领域.本文综述了近年来钯(II)类抗肿瘤药物的研究进展,并探讨了其构效关系,这对于指导新型钯(II)类抗肿瘤药物的合成具有重要的参考价值.  相似文献   

9.
烷氧基酸为离去基团的铂(Ⅱ)配合物的体外活性研究   总被引:1,自引:0,他引:1  
合成了5个以直链和带支链烷氧基乙酸为载体配基的顺铂类配合物,通过红外光谱、核磁共振氢谱和质谱对配合物进行了表征,并测试了化合物对肺腺癌SPC-A1和胃腺癌BGC823的体外抗肿瘤活性。生物活性测试结果表明,配合物的活性与离去基团有很大关系。配合物4(顺-二(异丙氧基乙酸根)·[(1R,2R)-1,2-反式环己二胺]合铂(Ⅱ))在2个细胞系中均显示最高的体外抗肿瘤活性,甚至超过顺铂。  相似文献   

10.
合成了阿司匹林铜(Ⅱ)配合物,通过红外、X射线单晶衍射对其结构进行了表征。配合物属单斜晶系,P21/n空间群,晶胞参数为a=8.211(5)nm,b=10.419(5)nm,c=21.003(5)nm,β=98.021(5)°,V=1779.2(14)nm3,Z=4。采用紫外光谱和荧光光谱法及循环伏安法研究了配合物与小牛胸腺DNA(ct-DNA)的相互作用。采用MTT法测定了配合物对体外培养人乳腺癌MCF-7和胃癌MGC-803细胞的抑制活性。当配合物浓度为120μmol/L时,对2种细胞增殖的抑制率分别为80.01%和70.16%。  相似文献   

11.
本文合成了9种含有由天然D( )鄄樟脑衍生的1R,3S鄄1,2,2鄄三甲基鄄1,3鄄环戊二胺(A)为配体的铂髤配合物[Pt髤AX]{其中,X=(CH2)3C(COO-)2(1,1鄄环丁烷二羧酸根),2CH3OCH2COO-,2CH3CH2OCH2COO-,2CH3(CH2)3OCH2COO-,[OCH(CH3)COO]2-(乳酸根),(OCH2COO)2-(乙醇酸根),2CH3OCH2CH2OCH2COO-,2CH3CH2OCH2CH2OCH2COO-和2CH3(CH2)3OCH2CH2OCH2COO-}。通过元素分析、热重分析、红外光谱、1H核磁共振谱和电喷雾质谱等对配合物进行了表征。体外生物活性测试表明,部分配合物对A549人肺癌细胞和HCT鄄116人结肠癌细胞具有较强的抗肿瘤活性。  相似文献   

12.

A series of novel trans-mixed diamine platinum(II) and platinum(IV) complexes of type trans-[PtII(R-NH2)(R'-NH2)Cl2] and trans -[PtIV(R-NH2)(R'-NH2)Cl4] (where R-NH2 = ethylamine or butylamine and R'-NH2 = methylamine, propylamine, isopropylamine, pentylamine, or hexylamine) was synthesized and characterized using elemental analysis and infrared and 195Pt nuclear magnetic resonance spectroscopic techniques.  相似文献   

13.
本文合成了9种含有由天然D(+)-樟脑衍生的1R,3S-1,2,2-三甲基-1,3-环戊二胺(A)为配体的铂(Ⅱ)配合物[Pt(Ⅱ)AX]{其中,X=(CH2)3C(COO-)2(1,1-环丁烷二羧酸根),2CH3OCH2COO-,2CH3CH2OCH2COO-,2CH3(CH2)3OCH2COO-,[OCH(CH3)COO]2-(乳酸根),(OCH2COO)2-(乙醇酸根),2CH3OCH2CH2OCH2OO-,2CH3CH2OCH2CH2OCH2COO-和2CH3(CH2)3OCH2CH2OCH2COO-).通过元素分析、热重分析、红外光谱、1H核磁共振谱和电喷雾质谱等对配合物进行了表征.体外生物活性测试表明,部分配合物对A549人肺癌细胞和HCT-116人结肠癌细胞具有较强的抗肿瘤活性.  相似文献   

14.
Introduction Cisplatinisoneofthemostactivechemotherapeu ticagentsavailableforthetreatmentofavarietyof cancers,especiallytesticularcancerandovariancanc er.However,itsclinicalutilityisrestrictedbyboththe drugresistanceandtoxicity.Sincethediscoveryofan tican…  相似文献   

15.
The complexes [Pt(3′′‐clpbpy)Cl2] ( 1 ) [3′′‐clpbpy = 4‐(3′′‐chlorophenyl)‐6‐phenyl‐2, 2′‐bipyridine], [Pt(4′′‐clpbpy)Cl2] ( 2 ) [4′′‐clpbpy = 4‐(4′′‐chlorophenyl)‐6‐phenyl‐2, 2′‐bipyridine], [Pt(3′′‐brpbpy)Cl2] ( 3 ) [3′′‐brpbpy = 4‐(3′′‐bromophenyl)‐6‐phenyl‐2, 2′‐bipyridine], and [Pt(4′′‐brpbpy)Cl2] ( 4 ) [4′′‐brpbpy = 4‐(4′′‐bromophenyl)‐6‐phenyl‐2, 2′‐bipyridine] were synthesized and characterized. The binding of the complexes with herring sperm DNA (HS DNA) was investigated by absorption titration and viscosity measurements. It was found that the complexes have ability of interaction with DNA by covalent mode. The intrinsic binding constant Kb of the complexes with HS DNA is 8.76 × 104 ( 1 ), 9.89 ×104 ( 2 ), 1.52 × 105 ( 3 ), and 2.31 × 105 ( 4 ) M–1. The slight depression in relative specific viscosity was observed, which also attributes to covalent binding of complexes with DNA bases. Gel electrophoresis assay demonstrated the ability of the complexes to unwind negatively supercoiled pUC19 plasmid by 14° ( 1 ), 13° ( 2 ), 13° ( 3 ), and 11° ( 4 ). The in vitro cytotoxic property of the synthesized metal complexes was also carried out against brine shrimp bioassay.  相似文献   

16.
Water-soluble phosphonate-functionalized triaryl phosphine ligands Na(2)[Ph(2)P(4-C(6)H(4)PO(3))].1.5H(2)O (4a), Na(2)[Ph(2)P(3-C(6)H(4)PO(3))].2H(2)O (4b), and Na(2)[Ph(2)P(2-C(6)H(4)PO(3))].2H(2)O (4c), were prepared in 54-56% yields by the transesterification and hydrolysis of the appropriate phosphonic acid diethyl ester precursors. The solubilities of 4a-c in water are compared and the spectroscopic properties studied in detail. The crystal structure of Na(2)[Ph(2)P(4-C(6)H(4)PO(3))(H(2)O)(3)(CH(3)OH)].CH(3)OH (monoclinic, P2(1)/n, a = 6.4457(8) ?, b = 8.1226(8) ?, c = 46.351(3) ?, beta = 92.902(8) degrees, Z = 4) shows a dimeric association via two bridging water molecules and four sodium ions. Reaction of 4a with PtCl(2)(PPh(3))(2) in a biphasic H(2)O/CH(2)Cl(2) mixture gives cis- and trans-Na(4)[PtCl(2){Ph(2)P(4-C(6)H(4)PO(3))}(2)]. 3H(2)O. Palladium dichloride and 4a in H(2)O/benzene catalyzes the carbonylation of benzyl chloride to give phenylacetic acid (91%).  相似文献   

17.
2,4-Dinitrophynylhydrazine and two thiocyanate ions in a (M:L1:L2) 1:2:2 molar ratio was synthesized in the complexes of Co(II) and Ni(II). The prepared compounds were identified through a C.H.N.S. analysis, conductivity measurements, powder X-ray diffraction (PXRD), the infrared spectrum, and a UV-visible spectrum analysis, in addition to the magnetic properties being measured. The measurements of the molar conductance implieda nonelectrolytic nature of compounds Co(II) and Ni(II). The magnetic susceptibility, as well as electronic spectra, represented all the metal complexesthroughoctahedral geometry, respectively. The PXRD patterns suggested that all the complexes were an orthorhombic system with unit cell parameters. The in-vitro biological activity of the ligand and the metal complexes were screened against the Gram-positive and negative pathogenic bacteria Staphylococcus aureus, Bacillus subtilis, Pseudomonas, aeruginosa and Escherichia coli, as well as the fungal species of Aspergillusniger and Candida albicans.Thus, the metal complexes showeda high efficiency of antimicrobial activity compared with the ligand. Furthermore, applications of the ligand, as well as the metal complexes, were tested for in-vitro antioxidant potential in aDPPH assay. The results showed that the activity of the metal complexes with the in-vitro antioxidant was more active than that of 2,4-dinitrophenylhydrazine(DNPH).  相似文献   

18.
Abstract

A series of cationic platinum(II) complexes of the type [Pt(cis-1,4-DACH)(R′R″S)Cl]NO3 and [Pt(PIP)2(R′R″S)Cl]NO3 (where cis-1,4-DACH = cis-1,4-diaminocyclohexane; PIP = piperidine; and R′R″S = dimethylsulfide, diethylsulfide, dipropylsulfide, diisopropylsulfide, dibutylsulfide, diphenylsulfide, dibenzylsulfide, methylphenylsulfide, or methyl-p-tolylsulfide) have been synthesized and characterized by elemental analysis and infrared, 1H, and 195Pt nuclear magnetic resonance spectroscopy.  相似文献   

19.
<正>由于特殊的分子构型及电子排布,具有平面四边形构型的多吡啶Pt(Ⅱ)络合物能够产生许多特殊的、具有潜在应用价值的激发态性质.本论文设计、合成了一系列以三联吡啶、6-苯基-2,2’-二联吡啶、菲啰啉为主配体,取代苯乙炔为辅助配体的多吡啶Pt(Ⅱ)络合物,系统地研究了它们的光物理性质,取得如下有意义的研究结果:  相似文献   

20.
Abstract

A new series of water soluble platinum(II) complexes of the type [Pt(DACH)[R-CH(COO)2]], wherein DACH represents IR,2R-cyclohexanediamine and R represents formamido. acetamido, (penta-O-acctyl-gluconyl)amino, and gluconylamino have been synthesized. The modes of binding of amidodicarboxylic acid derivatives in these complexes have been determined by various spectroscopic techniques: 1H, 13 C, and 195PtNMR; 2D-COSY{1H-1H} and 2D-HETCOSY{1H-13C} NMR, MS(FAB), IR and conductivity measurements.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号